Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02327741Completed
Open-label trial of clopidogrel in coronary artery disease (CAD), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Number of Patients With Major Bleeding Need Transfusion at 12 months. Started Oct 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02327741.